felodipine has been researched along with Lung Diseases, Obstructive in 7 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 10 patients with advanced chronic lung disease and pulmonary hypertension central haemodynamics and pulmonary gas exchange were studied at rest and during exercise, before and during continuous infusion of the calcium antagonist felodipine, which lowers vascular resistance by selective action on vascular smooth muscle." | 7.67 | The effect of a new calcium antagonist, felodipine, on pulmonary hypertension and gas exchange in chronic obstructive lung disease. ( Bratel, T; Hedenstierna, G; Nyquist, O; Ripe, E, 1985) |
| "In 10 patients with advanced chronic lung disease and pulmonary hypertension central haemodynamics and pulmonary gas exchange were studied at rest and during exercise, before and during continuous infusion of the calcium antagonist felodipine, which lowers vascular resistance by selective action on vascular smooth muscle." | 3.67 | The effect of a new calcium antagonist, felodipine, on pulmonary hypertension and gas exchange in chronic obstructive lung disease. ( Bratel, T; Hedenstierna, G; Nyquist, O; Ripe, E, 1985) |
| " We have compared the pulmonary vasodilator effects, dose-response characteristics, and tolerability of two calcium channel blockers, amlodipine and extended-release (ER) felodipine, in 10 patients (seven men, age 68+/-4." | 2.68 | A comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPD. ( Alpers, JA; Bune, AJ; Frith, PA; McEvoy, RD; Sajkov, D; Wang, T, 1997) |
| " Further dosage adjustments are made in accordance with a set protocol." | 2.67 | The Hypertension Optimal Treatment (HOT) Study--patient characteristics: randomization, risk profiles, and early blood pressure results. ( Hansson, L; Zanchetti, A, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansson, L | 1 |
| Zanchetti, A | 1 |
| Sajkov, D | 2 |
| McEvoy, RD | 2 |
| Cowie, RJ | 1 |
| Bradley, JA | 1 |
| Antic, R | 1 |
| Morris, RG | 1 |
| Frith, PA | 2 |
| Wang, T | 1 |
| Bune, AJ | 1 |
| Alpers, JA | 1 |
| Bratel, T | 4 |
| Hedenstierna, G | 4 |
| Nyquist, O | 4 |
| Ripe, E | 4 |
| Lundquist, H | 1 |
2 trials available for felodipine and Lung Diseases, Obstructive
| Article | Year |
|---|---|
The Hypertension Optimal Treatment (HOT) Study--patient characteristics: randomization, risk profiles, and early blood pressure results.
Topics: Adrenergic beta-Antagonists; Age Distribution; Aged; Aged, 80 and over; Angiotensin-Converting Enzym | 1994 |
A comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPD.
Topics: Aged; Amlodipine; Calcium Channel Blockers; Cross-Over Studies; Delayed-Action Preparations; Dose-Re | 1997 |
5 other studies available for felodipine and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Felodipine improves pulmonary hemodynamics in chronic obstructive pulmonary disease.
Topics: Aged; Blood Pressure; Cardiac Output; Echocardiography, Doppler; Felodipine; Female; Humans; Hyperte | 1993 |
The use of a vasodilator, felodipine, as an adjuvant to long-term oxygen treatment in COLD patients.
Topics: Aged; Blood Gas Monitoring, Transcutaneous; Felodipine; Female; Hemodynamics; Humans; Lung Diseases, | 1990 |
Cardiac function and central haemodynamics in severe chronic obstructive lung disease. Acute and long-term effects of felodipine.
Topics: Aged; Cardiac Output; Felodipine; Female; Heart; Hemodynamics; Humans; Lung Diseases, Obstructive; M | 1988 |
Long-term treatment with a new calcium antagonist, felodipine, in chronic obstructive lung disease.
Topics: Calcium Channel Blockers; Dose-Response Relationship, Drug; Exercise Test; Felodipine; Humans; Hyper | 1986 |
The effect of a new calcium antagonist, felodipine, on pulmonary hypertension and gas exchange in chronic obstructive lung disease.
Topics: Adult; Aged; Calcium Channel Blockers; Dose-Response Relationship, Drug; Felodipine; Female; Hemodyn | 1985 |